BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8650976)

  • 21. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
    Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
    Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Katamura Y; Takaki S; Waki K; Hiramatsu A; Takahashi S; Hieda M; Kakizawa H; Chayama K
    J Vasc Interv Radiol; 2010 Aug; 21(8):1219-25. PubMed ID: 20619676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.
    Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y
    Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
    Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin].
    Bokemeyer B; Grote R; Schmoll E; Freise J; Schmoll HJ; Galanski M; Schüler A; Schmidt FW
    Dtsch Med Wochenschr; 1989 Jan; 114(4):128-32. PubMed ID: 2536606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma.
    Imaoka S; Sasaki Y; Shibata T; Fujita M; Kasugai H; Kojima J; Ishiguro S; Ohigashi H; Ishikawa O; Fukuda I
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S126-8. PubMed ID: 2538259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, Lipiodol, and Gelfoam. A phase II study.
    Civalleri D; Pellicci R; Decaro G; Giangaspero A; Ettorre G; Decian F; Mondini G; Simoni G
    Anticancer Res; 1996; 16(2):937-41. PubMed ID: 8687155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New approach in chemoembolization of hepatocellular carcinoma--lipiodol, cisplatin sandwich therapy].
    Sasaki Y; Imaoka S; Iwanaga T; Miyoshi Y; Ishikawa O; Ohigashi H; Kasugai H; Kojima J; Tanaka S; Fujita M
    Nihon Gan Chiryo Gakkai Shi; 1986 Apr; 21(3):647-54. PubMed ID: 3016124
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
    Bhattacharya S; Dusheiko GM
    Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam.
    Ngan H; Lai CL; Fan ST; Lai EC; Yuen WK; Tso WK
    Clin Radiol; 1993 May; 47(5):315-20. PubMed ID: 8389682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined arterial and intraportal therapy of hepatocellular carcinoma: preliminary results].
    Tarazov PG; Prozorovskiĭ KV; Polysalov VN
    Vopr Onkol; 1994; 40(7-12):349-53. PubMed ID: 7610635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
    Pirschel J; Lauchart W
    Helv Chir Acta; 1993 Mar; 59(4):631-6. PubMed ID: 8386147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
    Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
    Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraarterial injection therapy of newly developed cisplatin-phosphatidyl choline-lipiodol suspension for hepatocellular carcinoma.
    Isomoto I; Aikawa H; Mori H; Matsunaga N; Ajimu A; Fukuda T; Ogasawara M
    Radiat Med; 1992; 10(1):19-25. PubMed ID: 1374923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
    Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemoembolization therapy in small hepatocellular carcinoma].
    Uchida H; Matsuo N; Sakaguchi H; Nishimine K; Anai H; Ohishi H
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):840-8. PubMed ID: 8678531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.